Novo Integrated Sciences Overview
Novo Integrated Sciences (NVOS) has a ROE of -1.09%, below the Industrials sector average of 22.38%.
Get informed when a big investor buys or sells
+ Follow-108.56%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for NVOS is -1.09%. That is below the Industrials sector average of 22.38%. Investors often review this figure alongside Novo Integrated Sciences's historical trend and sector peers before judging valuation or financial health.
Against Industrials companies, NVOS currently prints -1.09% for ROE, while the sector average sits near 22.38%. That is roughly 585.1% below the sector mean. Large gaps often invite a closer look at Novo Integrated Sciences's growth, margins, and balance sheet.
Return on Equity shows how effectively Novo Integrated Sciences converts resources into returns. At -1.09%, NVOS may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting NVOS's ROE (-1.09%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Novo Integrated Sciences's ROE against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.
